Protease Allergens Linked to Sensory Neuron Changes

Researchers found that exposure to protease allergens reprograms neurons to heighten immune responses.

Updated on Sept. 28, 2026 in Allergies

A close-up macro view of a translucent cellular sample on a glass laboratory slide, reflecting clinical lighting.
Researchers have identified a cellular pathway in sensory neurons that triggers metabolic changes, explaining why some allergic reactions intensify after repeated allergen exposure. AI Illustration. Upload story photo >

Scientists have discovered that protease allergens induce metabolic reprogramming within sensory neurons. This process creates a trained neuroimmune state that enhances the body’s reaction to repeated allergen exposure.

Why it matters

Understanding how sensory neurons adapt after allergen contact offers insight into why allergic reactions can intensify over time. This discovery identifies a specific cellular mechanism that dictates long-term neuroimmune sensitivity.

Bulk RNA sequencing identified metabolic pathway upregulation in trigeminal ganglia neurons 7 days after initial papain exposure. The study also observed mTORC1 activation and mitochondrial remodeling in skin-resident peptidergic sensory neurons.

The players

TRPV1 peptidergic sensory neurons

These specialized nerve cells are located in the skin and play a critical role in detecting and responding to environmental allergens.

The details

Protease allergens trigger a sequence of events including mTORC1 activation and phosphorylation of ribosomal protein S6 in peptidergic sensory neurons. Genetic deletion of the Rptor protein prevents the enhanced scratching and substance P release typically seen upon allergen re-exposure, while Tsc1 deletion increases the initial allergic response.

Timeline

  1. Bulk RNA sequencing occurred 7 days after initial exposure to the protease allergen papain.

The Big Picture

This discovery marks a significant expansion of the study of neuroimmune trained immunity by demonstrating how specific metabolic pathways sustain allergen sensitivity.

These findings suggest that future therapeutic approaches could target neuronal metabolic pathways to mitigate chronic allergic inflammation. Patients may eventually see treatments that prevent the neurological sensitization that drives severe reactions.

The takeaway

Allergies involve not just the immune system, but complex metabolic shifts within the nervous system. Implementing strategies that block specific protein signaling pathways in the future could potentially disrupt the cycle of recurring hypersensitivity.

Further reading

For more on the biological mechanisms behind chronic reactions, visit the Allergies section.

Source note: This article includes information reported by Nature.